dc.date.accessioned2021-09-29T20:02:45Z
dc.date.available2021-09-29T20:02:45Z
dc.date.created2021-09-29T20:02:45Z
dc.date.issued2020
dc.identifierhttps://hdl.handle.net/20.500.12866/9761
dc.identifierhttps://doi.org/10.1016/j.jcmg.2019.12.005
dc.description.abstractThe burden of cardiovascular disease in people living with HIV (PLWH) has tripled over the last 20 years, with cardiac manifestations of disease ranging from coronary disease to heart failure (1). The pathophysiological mechanisms involved in the development of HIV cardiomyopathy remain elusive. Subclinical structural and functional changes have been demonstrated in PLWH, but studies that used advanced imaging techniques focused on patients already treated with antiretroviral therapy (ART), potentially limiting the understanding of cardiac manifestations of HIV...
dc.languageeng
dc.publisherElsevier
dc.relationJACC. Cardiovascular Imaging
dc.relation1876-7591
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectMyocardial Inflammation
dc.subjectEdema
dc.subjectHuman Immunodeficiency Virus
dc.subjectHIV
dc.titleMyocardial Inflammation and Edema in People Living With Human Immunodeficiency Virus
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución